“We talk about technology a lot, but let’s remember why we’re here—to create precise solutions to meet patient needs.”
William Dalton, during the AI fireside chat.
Events kicked off with the awards ceremony on Sunday evening. Many pioneers were awarded this evening, including Dr. Carl June, the developer of CAR T therapy (CAR stands for, chimeric antigen receptor), the world’s first gene-based cancer therapy. Clinical trials of CAR T therapy began at the University of Pennsylvania in 2010 and in the time following, multiple advanced stage, chemotherapy-resistant patients have received the therapy for chronic lymphocytic leukemia (CLL) and remain in remission. Understanding how to harness the immune system to fight cancer, understanding the risks and how to mitigate, and how to apply immunotherapy to diverse cancer indications are ongoing in this groundbreaking field. We congratulate and thank the service of Dr. June and all teams and families involved.